针对管理基于价值合同的诊所提供建议的市场缺乏监管，质量差异很大，因此顾问的选择很大程度上决定结果，但转介往往更看重个人契合而非成本每episode分析的实际能力。 医疗服务提供商面临的结构性难题是：已在38,000个生命上承担下行风险，却缺乏定价所需的分episode成本数据。任何可信的方案都必须同时掌握分episode成本与付款人组合，而这正是大多数内部分析停止的地方，因为这两类数据存在于不同系统中。
针对管理基于价值合同的诊所提供建议的市场缺乏监管，质量差异很大，因此顾问的选择很大程度上决定结果，但转介往往更看重个人契合而非成本每episode分析的实际能力。 医疗服务提供商面临的结构性难题是：已在38,000个生命上承担下行风险，却缺乏定价所需的分episode成本数据。任何可信的方案都必须同时掌握分episode成本与付款人组合，而这正是大多数内部分析停止的地方，因为这两类数据存在于不同系统中。
核心难点在于，购买这项服务的医务主任或CFO缺乏内部的分episode成本数据，无法判断建议能否改善38,000个归属生命的利润率，也没有标准资质能证明某人在将付款人组合与实际贡献对齐方面的专业能力。
这些诊所反复出现的问题归结为几个基于现有数据的计算：某些服务线在扣除全部成本后是否产生正的每提供者贡献，面板规模增长是受限于产能还是合同条款，转化周期如何影响现金流（尽管基于价值合同下整体盈利），以及领导层时间本身是否限制了绩效。
需要避免的模式是对每次委托都套用相同步骤，而不参考付款人组合或分episode成本拆解，通常包括合同重新谈判、人员扩张或系统实施的标准化建议，只有当底层约束与干预措施匹配时才会成功。
诊断方法将每提供者贡献和分episode成本与基于价值合同下的归属生命进行对照，以识别哪些杠杆可用、什么限制了进一步进展，并提供一个低承诺步骤，判断持续支持还是运营招聘是合适下一步。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 提案先列出固定步骤序列，而未首先在当前付款人组合上映射分episode成本。
✓ 在审查每提供者贡献数据之前，就提出面板规模或提供者组合的调整建议。
✓ 顾问无法提供其此前在基于价值条款上的指导产生比预期更差结果的合同案例。
通常会让情况更糟的做法。 基于转介中的个人关系做出选择，这能预测讨论过程中的舒适度，却无法预测指导是否匹配分episode成本和面板规模数字中可见的具体约束。
It is for you if you run or finance a healthcare provider and the proposal describes a programme rather than a diagnosis. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家医疗服务提供商. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Turn $6.8 M downside-risk liability into a $22–35 M licensing platform within 36 months.
The leak it closes. Eliminates $6.8 M downside exposure by enabling proactive utilization management.
The assumption it rests on. Cost-measurement platform achieves <5 % variance versus manual abstraction within 12 months — the engine put the probability at 0.75.
| Investment required | $2.1–3.5 M over 36 months |
| Expected return | 6.3–16.7× cash-on-cash within 36 months based on $196 M current revenue base. |
| Revenue, year 1 | $0 licensing revenue; $1.8 M internal cost avoidance |
| Revenue, year 2 | $4.2 M licensing ARR (40 physicians × $120K + 5 external practices × $400K) |
| Revenue, year 3 | $13.5 M licensing ARR (90 physicians × $120K + 18 external practices × $400K) plus $4–8 M shared-savings upside |
| Exit criteria | Terminate platform investment if variance exceeds 8 % by Month 18 OR if fewer than 40 physicians sign licensing agreements by Month 24; redeploy remaining capital to ASC surgeon-retention track. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 增长策略, one of 29 engagements the platform runs. For 医疗服务提供商 it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
针对一项明确工作——定价审查、盈利能力分析、增长诊断——£3k–£15k是正常的中端市场区间，通常足够。开放式的月度retainer £1,500–£5,000很常见，只有在有持续交付而非持续建议时才值得。如果每月支付的是会议费，这些会议就应该产生你能说清的决策。
更多时候是后者，而市场承认的程度不够。小型企业战略问题的很大一部分，答案就在于把企业已经产生、却只以总量查看的数字拆开。如果从未有人给你展示按产品、按客户、按渠道的贡献，那么这项分析就是第一笔购买，而且费用不高。
教练针对所有者，顾问针对业务本身。教练处理你正在回避的决策、习惯和问责，确实对部分所有者有帮助。顾问处理正确的决策是什么。混淆两者很常见，而为问责支付咨询费用是代价更高的错误方向。
Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · العربية · Tiếng Việt · ไทย · हिन्दी · עברית